Cervical cancer screening guidelines in the U.S. recommend that most women can discontinue routine screening at age 65 after ...

HPV is fuelling high cervical cancer rates in sub-Saharan Africa despite the availability of effective vaccines. Yet uptake remains l ...

Despite advancements in medical science, cervical cancer remains a leading cause of death among South African women. This ...

Screening and early detection, as well as the introduction of a human papillomavirus (HPV) vaccine, have fuelled transformative strides in decreasing the burden of cervical cancer for women and ...

Sydney-based biotech TruScreen Group (ASX: TRU) has launched a five-year cervical screening program in Vietnam using its ...

TruScreen Group (ASX: TRU) has initiated a five-year cervical screening program in Ho Chi Minh City, Vietnam, leveraging its AI-enabled TruScreen Ultra device. This community-based program, conducted ...

As a result, these patients should be referred for colposcopy (Figure 3). Repeat cytology and HPV testing are indicated for risk assessment only if colposcopic findings are negative for CIN.

Human papillomavirus (HPV) is necessary for the development of cervical carcinoma ... DNA testing in the triage of women with equivocal cytology and in follow-up after the treatment of precursor ...

Uterine carcinosarcoma, also referred to as malignant mixed Müllerian tumor, is a rare and highly aggressive neoplasm predominantly affecting postmenopausal women. Combining carcinomatous and ...